The Centers for Disease Control and Prevention Selects Avere Hybrid Cloud Solution to Support Its Next Generation Genomic Sequencing Environment
(firmenpresse) - PITTSBURGH, PA -- (Marketwired) -- 11/11/14 -- , a leading provider of enterprise storage for the hybrid cloud, today announced that the (CDC) has selected Avere to help scale datacenter performance and capacity for its new genomic sequencing environment. Avere will be supporting the CDC's Office of Infectious Diseases (OID), which aims to lead, promote, and facilitate science, programs and policies to reduce the burden of infectious diseases in the United States and across the globe.
After taking steps to improve its high performance computing environment and instruments, the CDC found that it required an additional 3.5 petabytes of usable storage and a solution that would improve performance and data transfer between campus systems while maintaining ease of use for the scientists. Finally, the CDC needed to ensure that future expansion of the data center would easily be accommodated.
"When Avere heard what the CDC required for its datacenter strategy and to support the next generation of genomic sequencing platforms, we knew that Avere FXT Edge filers would be the ideal fit," said Ron Bianchini, president and CEO, Avere Systems. "We offer the performance, scale and manageability required to empower the CDC to focus on its life-saving mission, rather than worry about the backend infrastructure keeping up."
The next generation sequencing environment is being powered by Avere FXT 3850 Edge filers with FlashMove and FlashMirror. Both FlashMove and FlashMirror make managing the data center easy and reliable. FlashMove migrates live data simply, and non-disruptively between multiple sources including NAS filers, private and/or public clouds. FlashMirror replicates the data between the sources and thanks to the Avere global namespace, if the primary storage filer goes offline, the secondary source is utilized without slowing down productivity for users.
Avere is radically changing the economics of data storage. Avere's hybrid cloud solutions give companies -- for the first time -- the ability to put an end to the rising cost and complexity of data storage by allowing customers the freedom to store files anywhere in the cloud or on premises without sacrificing the performance, availability or security of their data. Based in Pittsburgh, Avere is led by veterans and thought leaders in the data storage industry and is backed by investors Lightspeed Venture Partners, Menlo Ventures, Norwest Venture Partners, Tenaya Capital, and Western Digital Capital. For more information, visit .
Media Contact:
USA:
Bhava Communications for Avere Systems
Amber Winans
510-984-1526
Rest of World:
Omarketing for Avere Systems
Rose Ross
+44-208-255-5225
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.11.2014 - 14:00 Uhr
Sprache: Deutsch
News-ID 351498
Anzahl Zeichen: 0
contact information:
Town:
PITTSBURGH, PA
Kategorie:
Hardware
Diese Pressemitteilung wurde bisher 180 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Centers for Disease Control and Prevention Selects Avere Hybrid Cloud Solution to Support Its Next Generation Genomic Sequencing Environment"
steht unter der journalistisch-redaktionellen Verantwortung von
Avere Systems (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
